QuorumCivic. Hidden in plain sight Get the app
Bill intelligence

Congress bans life-devaluing math from Medicare, Medicaid decisions

H.R. 3864 — Protecting Health Care for All Patients Act of 2025 · Filed by Kat Cammack (R-FL) · 3 cosponsors · Introduced Jun 10, 2025 · Referred to committee

55%
Transparency
Typical bill: 82%
25/100
Hidden-provision risk
Typical bill: 15/100
Disability Rights & Healthcare Access…

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill prohibits federal health care programs (Medicare, Medicaid, CHIP, Medicare Advantage, and Part D) from using quality-adjusted life years (QALYs) and similar cost-effectiveness measures to make coverage and payment decisions. QALYs are metrics that assign lower value to extending the lives of elderly, disabled, or terminally ill people compared to younger, healthier individuals. The bill also increases funding for the Prevention and Public Health Fund and requires annual reporting on how QALYs affect people with intellectual and developmental disabilities.

Why we flagged it

The bill's core function is to protect vulnerable populations (elderly, disabled, terminally ill) from algorithmic discrimination in health care coverage decisions by banning a specific cost-effectiveness metric. This is fundamentally a civil rights and access protection measure, not a market intervention.

What the text implies

  • May increase health care costs by preventing use of cost-effectiveness analysis in coverage decisions, potentially shifting burden to taxpayers or other beneficiaries through higher premiums or reduced coverage elsewhere.
  • Applies a blanket prohibition without carve-outs for extreme cost scenarios, potentially limiting legitimate cost-containment tools in resource-constrained programs.

The full analysis lists 5 implications of this text.

Who stands to gain

Pharmaceutical companies (may face fewer cost-effectiveness barriers to coverage); Medical device manufacturers (similar coverage expansion incentives); Healthcare providers treating elderly and disabled populations (expanded treatment authorization)

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record